Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
- 29 May 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 381 (9885), 2273-2279
- https://doi.org/10.1016/s0140-6736(13)61125-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genomeThe Lancet, 2013
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) VirusNew England Journal of Medicine, 2013
- Global Assessment of Resistance to Neuraminidase Inhibitors, 2008–2011: The Influenza Resistance Information Study (IRIS)Clinical Infectious Diseases, 2013
- Seasonal Influenza A Virus in Feces of Hospitalized AdultsEmerging Infectious Diseases, 2011
- Clinical and Virological Factors Associated with Viremia in Pandemic Influenza A/H1N1/2009 Virus InfectionPLOS ONE, 2011
- Viral Clearance and Inflammatory Response Patterns in Adults Hospitalized for Pandemic 2009 Influenza A(H1N1) Virus PneumoniaAntiviral Therapy, 2010
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemiaNature Medicine, 2006
- Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitroJournal of Antimicrobial Chemotherapy, 2006
- Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by ComaThe New England Journal of Medicine, 2005
- Molecular mechanisms of influenza virus resistance to neuraminidase inhibitorsVirus Research, 2004